Pharmacokinetic/pharmacodynamic (PK/PD) model for tolvaptan (TOL) in patients with congestive heart failure (CHF) and/or hyponatremia (HYP)

被引：0
|
作者：
Van Wart, SA [1 ]
Cirincione, BB [1 ]
Ludwig, EA [1 ]
Chen, X [1 ]
Shoaf, S [1 ]
Grasela, TH [1 ]
Mallikaarjun, S [1 ]
机构：
[1] Cognigen Corp, Otsuka Maryland Res Inst, Buffalo, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P1 / P1
页数：1
相关论文
共 50 条
  • [11] A new pharmacokinetic/pharmacodynamic model (PK/PD) for mivacurium
    Laurin, J
    Nekka, F
    Donati, F
    Varin, F
    ANESTHESIOLOGY, 1996, 85 (3A) : A323 - A323
  • [12] A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure
    McElnay, JC
    AlFuraih, TA
    Hughes, CM
    Scott, MG
    Nicholls, DP
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 49 (06) : 471 - 476
  • [13] Population pharmacokinetic (PK)-pharmacodynamic (PD) model for gefitinib in cancer patients.
    Li, J
    Karlsson, MO
    Brahmer, J
    Cusatis, G
    Hidalgo, M
    Baker, SD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 212S - 212S
  • [14] Economic Burden of Prolonged Hyponatremia in Patients Admitted with Congestive Hear Failure (CHF) and Hyponatremia
    Tabak, Ying P.
    Zilberberg, Marys
    Spalding, James
    Sun, Xiaowu
    Liu, Yan
    Gupta, Vikas
    Shorr, Andrew F.
    CIRCULATION, 2008, 118 (18) : S871 - S871
  • [15] Development of a pharmacokinetic/pharmacodynamic model for carvedilol to predict β1-blockade in patients with congestive heart failure
    Tenero, David M.
    Henderson, Linda S.
    Campanile, Andrea N.
    Baidoo, Charlotte A.
    Boyle, Duane
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (7A): : 27L - 31L
  • [16] Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosis
    Van Wart, Scott A.
    Shoaf, Susan E.
    Mallikaarjun, Suresh
    Mager, Donald E.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (06) : 336 - 347
  • [17] A PHARMACOKINETIC (PK) STUDY OF ORAL AND INTRAVENOUS (IV) AMLODIPINE (A) IN PATIENTS WITH MILD TO MODERATE HYPERTENSION (HTN) AND CONGESTIVE-HEART-FAILURE (CHF)
    JAIN, AK
    VARGAS, R
    GARDNER, MJ
    SOUHRADA, JF
    LAZAR, JD
    MCMAHON, FG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 171 - 171
  • [18] Pharmacokinetic (PK) pharmacodynamic (PD) model of FTY 720 in humans
    Marino, M
    Choudhury, S
    Neumayer, HH
    Brunkhorst, R
    Lucker, P
    Brookman, L
    Schmouder, R
    TRANSPLANTATION, 1999, 67 (07) : S205 - S205
  • [19] A population pharmacokinetic analysis of carvedilol in children with congestive heart failure (CHF)
    Tenero, D.
    Patel, B.
    Lukas, M. A.
    Shaddy, R.
    Boyle, D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1111 - 1111
  • [20] Population PK/PD models of moxonidine in patients with congestive heart failure.
    Karlsson, MO
    Swedberg, K
    Schaefer, HG
    Wiltse, C
    McNay, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 208 - 208
12345